Clorox (NYSE:CLX – Get Free Report) had its price target raised by equities researchers at TD Cowen from $98.00 to $111.00 in a note issued to investors on Tuesday,MarketScreener reports. The firm presently has a “hold” rating on the stock. TD Cowen’s target price would suggest a potential upside of 6.77% from the company’s previous close.
A number of other brokerages have also recently issued reports on CLX. Evercore decreased their price objective on shares of Clorox from $132.00 to $115.00 and set an “underperform” rating on the stock in a research note on Wednesday, February 4th. Rothschild & Co Redburn set a $117.00 target price on Clorox in a report on Friday, February 13th. Wall Street Zen upgraded Clorox from a “sell” rating to a “hold” rating in a research note on Saturday, February 7th. UBS Group boosted their price target on Clorox from $115.00 to $121.00 and gave the stock a “neutral” rating in a report on Wednesday, February 4th. Finally, The Goldman Sachs Group dropped their price objective on Clorox from $110.00 to $94.00 and set a “sell” rating for the company in a research report on Wednesday, January 7th. One analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and an average target price of $118.00.
Check Out Our Latest Stock Report on Clorox
Clorox Price Performance
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $1.39 EPS for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 11.17% and a return on equity of 383.01%. The firm’s revenue for the quarter was down .8% compared to the same quarter last year. During the same period last year, the firm earned $1.55 EPS. As a group, sell-side analysts predict that Clorox will post 7.15 earnings per share for the current year.
Institutional Trading of Clorox
A number of hedge funds have recently made changes to their positions in the company. Total Investment Management Inc. bought a new stake in Clorox in the second quarter valued at approximately $25,000. Center for Financial Planning Inc. bought a new position in Clorox during the 3rd quarter worth approximately $25,000. Vermillion & White Wealth Management Group LLC acquired a new position in shares of Clorox in the 3rd quarter worth approximately $25,000. Caitlin John LLC lifted its position in shares of Clorox by 1,807.1% in the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after purchasing an additional 253 shares during the period. Finally, True Wealth Design LLC boosted its stake in shares of Clorox by 1,020.0% in the 3rd quarter. True Wealth Design LLC now owns 224 shares of the company’s stock valued at $28,000 after purchasing an additional 204 shares during the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.
About Clorox
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Read More
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
